Biomarkers in Drug formulation

Drug formulation also covers the surrogate end points in the use of biomarkers and patient selection or companion diagnostics and provides insights into clinical biomarker discovery and biomarker development or validation with regulatory implications. Biomarker use can improve pharmaceutical development efficiency by helping to select patients most appropriate for treatment using a given mechanism, optimize dose selection, and provide earlier confidence in accelerating or discontinuing compounds in clinical development.

Biomarker in Drug discovery

 

Biomarker in Drug Design

 

Dose selection in Biomarker

 

Biomarkers of Toxicity & Pharmacology

 

Biomarkers in dose selection

 

Evaluation of dose respons

 

    Related Conference of Biomarkers in Drug formulation

    November 11-12, 2024

    9th Global Summit on Midwifery and Womens Health

    Dubai, UAE
    November 22-23, 2024

    5th Global Summit on Public Health

    Paris, France
    November 25-26, 2024

    10th World Holistic Nursing Conference

    Bali, Indonesia
    January 27-28, 2025

    10th World Congress on Public Health and Nutrition

    Bangkok, Thailand
    February 24-25, 2025

    21st Global Congress on Healthcare and Technologies

    Madrid, Spain
    March 17-18, 2025

    5th International conference on Healthcare Summit

    Singapore City, Singapore
    March 27-28, 2025

    7th International Conference on Digital Health

    London, UK
    April 07-08, 2025

    7th World Summit on Women's Health and Cancer Awareness

    Vancouver, Canada
    April 24-25, 2025

    4th International Congress on Global Healthcare

    Vienna, Austria
    May 14-15, 2025

    7th World Conference on Vaccine and Immunology

    Barcelona, Spain
    May 22-23, 2025

    International Congress on Primary Health and Safety

    Toronto, Canada
    July 23-24, 2025

    30th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    July 24-25, 2025

    36th European Heart and Heart Failure Congress

    Paris, France
    September 22-23, 2025

    21st Global Biomarkers and Clinical Research Summit

    Aix-en-Provence, France

    Biomarkers in Drug formulation Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in